SCHEMBL598661

SCHEMBL598661

CC(C)c1cccc(C(C)(C)C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.49
HDAC4 P56524 3/20 0.44
HDAC8 Q9BY41 3/20 0.44
ALDH1A1 P00352 3/20 0.44
HDAC2 Q92769 2/20 0.44
HPGD P15428 2/20 0.44
ALOX15 P16050 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MDM4 O15151 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
TYR P14679 1/20 0.44
ALOX12 P18054 1/20 0.44
CA5A P35218 1/20 0.44
HTT P42858 1/20 0.44
MDM2 Q00987 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4981920 0.86 KIF11 (0.49) KIF11HDAC4HDAC8ALDH1A1HDAC2
SCHEMBL16191335 0.86 KIF11 (0.49) KIF11HDAC4HDAC8ALDH1A1HDAC2
SCHEMBL17449153 0.84 ACHE (0.50) KIF11HDAC4HDAC8ALDH1A1HDAC2
SCHEMBL8968762 0.83 KIF11 (0.50) KIF11HDAC4HDAC8ALDH1A1HDAC2
SCHEMBL15836405 0.83 ACHE (0.49) KIF11HDAC4HDAC8ALDH1A1HDAC2
SCHEMBL24270379 0.83 KIF11 (0.46) KIF11HDAC4HDAC8ALDH1A1HDAC2
SCHEMBL10199855 0.83 PTPN5 (0.49) KIF11HDAC4HDAC8ALDH1A1HDAC2
SCHEMBL18793694 0.83 HDAC4 (0.41) KIF11HDAC4HDAC8ALDH1A1HDAC2
SCHEMBL20963009 0.83 KIF11 (0.46) KIF11HDAC4HDAC8ALDH1A1HDAC2
SCHEMBL14120875 0.83 HDAC4 (0.41) KIF11HDAC4HDAC8ALDH1A1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119708811-A Boron nitride-containing resin composition and application thereof 陕西生益科技有限公司 2025-03-28 CN claimed
CN-119708812-A Resin composition, metal foil-clad laminate and application thereof 陕西生益科技有限公司 2025-03-28 CN claimed
US-7700232-B2 Comprises an electrolyte salt in a non-aqueous solvent which contains a tert-alkylbenzene compound of high purity; battery improved in safety, excellent in cycle performance and storage performance at a high temperature, improved safety UBE INDUSTRIES, LTD. (JP) 2010-04-20 US claimed
US-20080248399-A1 Comprises an electrolyte salt in a non-aqueous solvent which contains a tert-alkylbenzene compound of high purity; battery improved in safety, excellent in cycle performance and storage performance at a high temperature, improved safety UBE INDUSTRIES, LTD. (JP) 2008-10-09 US claimed
US-6503662-B1 Tert-butylbenzene derivative prevents oxidation and decomposition of solvent at the time of charging which causes decreased battery characteristics UBE INDUSTRIES, LTD. (JP) 2003-01-07 US claimed
CN-1290974-A Nonaqueous electrolyte solution and lithium secondary battery using same UBE INDUSTRIES (JP) 2001-04-11 CN claimed
CN-119823516-A Polymer composite material, method of using the same, low dielectric resin composition, prepreg, and metal foil laminate 李长荣化学工业股份有限公司 2025-04-15 CN disclosed
CN-119708811-A Boron nitride-containing resin composition and application thereof 陕西生益科技有限公司 2025-03-28 CN disclosed
CN-119708812-A Resin composition, metal foil-clad laminate and application thereof 陕西生益科技有限公司 2025-03-28 CN disclosed
US-20230374230-A1 CROSSLINKED GEL FORMULATION ESSILOR INTERNATIONAL (FR) 2023-11-23 US disclosed
US-20230337520-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 US disclosed
EP-3774775-B1 4-OXO-3,4-DIHYDROQUINAZOLINE COMPOUNDS AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV HEALTHCARE UK NO 5 LTD (GB) 2023-10-11 EP disclosed
CN-116075529-A Method for producing aromatic ether compound having vinyl group 日铁化学材料株式会社 2023-05-05 CN disclosed
WO-2003051298-A2 PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES PHARMASSET LTD. (BB) 2003-06-26 WO disclosed
US-6503662-B1 Tert-butylbenzene derivative prevents oxidation and decomposition of solvent at the time of charging which causes decreased battery characteristics UBE INDUSTRIES, LTD. (JP) 2003-01-07 US disclosed
CN-1290974-A Nonaqueous electrolyte solution and lithium secondary battery using same UBE INDUSTRIES (JP) 2001-04-11 CN disclosed
US-5175135-A Using acid mordenite zeolite as alkylation catalysts to produce dialkylbiphenyl THE DOW CHEMICAL COMPANY (US) 1992-12-29 US disclosed
US-5004841-A Para-substitutions with crystalline acidic mordenite zeolite alkylation catalysts THE DOW CHEMICAL COMPANY (US) 1991-04-02 US disclosed
EP-0317907-A2 Alkylation of polycyclic aromatic compounds to alkylates enriched in the para-substituted isomers THE DOW CHEMICAL COMPANY (US) 1989-05-31 EP disclosed
US-4450279-A PHOTOPOLYMERIZATION SENSITIZERS FOR UNSATURATED MONOMERS; RAPID HARDENING; STORAGE STABILITY NIPPON, KAYAKU, KABUSHIKI, KAISHA (JP) 1984-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337520-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LBR, LPO, LPL KIF11 3016/4885HDAC4 3375/4885HDAC8 4170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.